Diabetes Flashcards

1
Q

how is the anion gap calculated and what is its normal value

A

Anion gap = [Na + K] - [HCO3 + Cl]
normally between 8 & 12 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what happens to the anion gap in DKA

A

elevated due to accumulation of ketoacids which are unmeasured anions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

why is calculating the anion gap important in clinical practice

A

differentiated between high anion gap metabolic acidosis and normal
- if high, alerts clinicians to investigate for potential toxins, critical illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are causes of a normal anion gap or hyperchloraemic metabolic acidosis

A
  • GI: diarrhoea, fistula
  • RTA
  • drugs e.g. acetazolamide
  • Addison’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are causes of a raised anion gap metabolic acidosis

A
  • lactate: shock, hypoxia
  • ketones: DKA, alcohol
  • urate: renal failure
  • acid poisoning: salicylates, methanol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is type 1 diabetes

A

autoimmune destructio of beta cells leading to absolute insulin deficiency
- without insulin, cells of body cannot absorb glucose from blood so levels keep rising causing hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are causes of T1DM

A

causes unclear - may be genetic
- Coxsackie B and enterovirus can trigger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the classic triad of symptoms of t1dm

A
  • polyuria
  • polydipsia
  • weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the ideal blood glucose concentration

A

4.4-6.1 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

where is insuli produced and what are its actions

A

beta cells in Islets of Langerhans
- anabolic
- causes cells to absorb glucose from the blood and use it as fuel
- causes muscle and liver cells to absorb glucose and store as glycogen (glycogenesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

where is glucagon produced and what are its actions

A

alpha cells in islets of langerhans
- catabolic hormone
- glycogenolysis and gluconeogenesis (proteins and fats into glucose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is ketogenesis

A

production of ketones when there is insufficient glucose supply and glycogen stores are exhausted e.g. in prolonged fasting
- liver takes fatty acids and converts them to ketones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are ketones

A

water-soluble fatty acids that can cross the BBB and be used as fuel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how can ketone levels be measured

A

in urine with urine dipstick
in blood with ketone meter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how are ketones buffered in healthy people

A

kidneys buffer ketones so the blood does not become acidotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are 3 common scenarios for DKA to occur

A
  • inital presentation of T1DM
  • existing T1DM whi is unwell w infection
  • exisitng T1DM not adhering to insulin regime
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are 3 key features of DKA

A
  • ketoacidosis
  • dehydration
  • K+ imbalance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how ketoacidosis arise in DKA

A
  • without insulin, cells of body cannot recognise glucose even when levels in blood are sufficient so the liver produces ketones as an alternative fuel source
  • over time, higher and higher glucose and ketones
  • initally kidneys will produce bicarb to counteract ketones to maintain normal pH
  • but over time, ketone acids use up the bicarb so the blood becomes acidic = ketoacidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

why does dehydration occur in DKA

A
  • hyperglycaemia overwhelms the kidneys and glucose leaks into the urine
  • glucose in the urine draws water out by osmotic diuresis = polyuria and polydipsia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what causes K+ imbalance in DKA

A
  • insulin normally drives K+ into cells so without insulin, K+ is not added to and stored in cells
  • serum K+ can be high or normal as the kideys balance blood K+ w K+ excreted in the urine but total body K+ is low
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

when patients with DKA are started on insulin, what electrolyte abormality occurs

A

hypokalaemia –> fatal arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are the criteria for diagnosing DKA

A
  • Hyperglycaemia (e.g., blood glucose above 11 mmol/L)
  • Ketosis (e.g., blood ketones above 3 mmol/L)
  • Acidosis (e.g., pH below 7.3)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how is DKA managed

FIGPICK

A
  • Fluids – IV fluid resuscitation with normal saline (e.g., 1 litre in the first hour, followed by 1 litre every 2 hours)
  • Insulin – fixed rate insulin infusion (e.g., Actrapid at 0.1 units/kg/hour)
  • Glucose – closely monitor blood glucose and add a glucose infusion when it is less than 14 mmol/L
  • Potassium – add potassium to IV fluids and monitor closely (e.g., every hour initially)
  • Infection – treat underlying triggers such as infection
  • Chart fluid balance
  • Ketones – monitor blood ketones, pH and bicarbonate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what criteria must be met before insulin and fluid infusions can be stopped in treatment of DKA

A
  • Ketosis and acidosis should have resolved
  • They should be eating and drinking
  • They should have started their regular subcutaneous insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what are 4 complications that can arise during treatment of DKA

A
  • Hypoglycaemia (low blood sugar)
  • Hypokalaemia (low potassium)
  • Cerebral oedema, particularly in children
  • Pulmonary oedema secondary to fluid overload or acute respiratory distress syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what are examples of autoantibodies in T1DM

A

Anti-islet cell antibodies
Anti-GAD antibodies
Anti-insulin antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what subtance can be used as a measure of insulin production

A

serum C-peptide
- low w low insulin and high w high insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what is an important side of effecting of injecting insulin

A

lipodystrophy where the s/c fat hardens
- areas of lipodystrophy do not absorb insulin properly so important to change injection sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

how do insulin pumps work

A

small devices that continuously infuse insulin at different rates to control blood sugar levels
- alternative to basal-bolus regime
- pump pushes insulin through a cannula inserted under the skin which is replaced every 2 – 3 days
- the insertion sites are rotated to prevent lipodystrophy and absorption issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what are advantages of using an insulin pump

A
  • better blood sugar control
  • more flexibility w eating
  • less injection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what are disadvantages of insulin pumps

A
  • Difficulties learning to use the pump
  • Having it attached at all times
  • Blockages in the infusion set
  • A small risk of infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what are 2 types of insulin pumps

A
  • tethered pump
  • patch pump
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

how do tethered insulin pumps work

A
  • devices with replaceable infusion sets and insulin
  • usually attached to the patient’s belt or around the waist with a tube connecting the pump to the insertion site
  • controls for the infusion are on the pump itself
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

how do patch insulin pumps work

A
  • sit directly on the skin without any visible tubes
  • when they run out of insulin, the entire patch pump is disposed of, and a new pump is attached
  • a separate remote usually controls patch pumps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

what are 3 management options of T1DM

A
  • basal-bolus regime
  • insulin pumps
  • pancreas transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

how does pancreas transplant work and what are its risks

A
  • implant donor pancreas to produce insulin
  • original pancreas left in place to continue producing digestive enzymes
  • ‼️ life-long immunosuppresion to prevent rejection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

in what patients is a pancreas transplant appropriate

A
  • those with severe hypoglycaemic episodes
  • those also having kidney transplants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

give 4 ways in which DM is monitored

A
  • HbA1c
  • CBG
  • flash glucose monitor e.g. freestyle libre
  • continuous glucose monitors (CGM)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

how often is HbA1c measured

A

reflects average glucose level over previous 2-3 months (rbc have lifespan of 4 months)
- measured every 3-6 months to track average blood sugar levels

40
Q

what do flash glucose monitors measure

A

glucose level of the interstitial fluid in the s/c tissue
- 5 min lag behind blood glucose

41
Q

what can cause hypoglycaemia

A
  • too much insulin
  • not consuming enough carbs
  • not processing carbs correctly e.g. malabsorption, vomiting, diarrhoea
42
Q

what are typical symptoms of hypoglycaemia

A
  • hunger
  • tremor
  • sweating
  • irritability
  • dizziness
  • severe: reduced consciousness, coma, death
43
Q

how is hypoglycaemia treated in adults who are conscious, orientated and able to swallow

A

initally with 15-20g rapid-acting glucose e.g. high sugar content drink
- once glucose levels improves, consume slower-acting carbs e.g. biscuits/toast to stop levels dropping agains

44
Q

how can severe hypoglycaemia be treated

A
  • IV dextrose
  • IM glucagon
45
Q

how do chronic high blood glucose levels cause damage

A
  • damage endothelial cells of blood vessels
  • causes leaky, malfunctioning vessels that are unable to regenerate
  • can also cause immune system dysfunction and create optimal environment for infectious organisms to thrive
46
Q

what are macrovascular complications of DM

A
  • CAD
  • peripheral ischaemia causing poor skin healing and diabetic foot ulcers
  • stroke
  • HTN
47
Q

what are microvascular compliccations of DM

A
  • peripheral neuropathy
  • retinopathy
  • kidney disease esp glomerulosclerosis
48
Q

what are other causes of neuropathy

A
  • diabetes
  • alcohol
  • B12 deficiency
  • B6 excess
  • chemo
49
Q

what are infection-related complications of DM

A
  • Urinary tract infections
  • Pneumonia
  • Skin and soft tissue infections, particularly in the feet
  • Fungal infections, particularly oral and vaginal candidiasis
50
Q

give 3 examples of ketone bodies

A
  • 3-beta-hydroxybutyrate
  • acetoacetic acid
  • acetone
51
Q

what are metabolic treatment targets of DKA

A
  • Reduction in blood ketones by 0.5mmol/l/hour
  • Increase venous bicarbonate by 3.0mmol/l/hour
  • Maintain potassium between 4 and 5.5mmol/l
  • If not achieved the FRIII should be increased
  • Introduce 10% dextrose when the blood glucose falls below 14mmol/l – alongside N saline and continue until patient is eating
    *
52
Q

when treating ketoacidosis, when can FRIII be switched to s/c insulin

A

when ketones <0.6mmol/L and ready to eat

53
Q

what is HHS and what are the specific features that differentiate it from DKA

A

hyperosmolar hyperglycaemic syndrome
- hypovolaemia
- marked hyperglycaemia >30mmol/L without significant hyperketonaemia <3mmol/L
- acidosis ph>7.3, bicarb >15mmol/L

54
Q

how do you calculate osmolality

A

2Na + glucose + urea

55
Q

what are the treatment goals of HHS

A
  • normalise osmolality
  • replace fluid and electrolyte lossed
  • normalise blood glucose
56
Q

key principles of fluids and insulin FRIII

A
  • Crystalloids
  • Aim to replace 50% of estimated loss within first 12 hours
  • FRIII 0.05 units/Kg/hour
  • Monitor potassium and renal function
  • Glucose fall 4 to 6mmol/hour
  • Remember treat co-morbidities
  • Anticoagulation
57
Q

what are risk factors of hypoglycaemia

A
  • medical issues: long duration of T1DM, renal failure on dialysis, AKI, impaired renal function, terminal illness
  • lifestyle issues: inc exercise, irregular lifestyle, inc age, alcohol, early pregnancy, breast feeding
  • reduced carb intake
58
Q

what are potential causes of inpatient hypoglycaemia

A

medical issues
- recovery from acute illness/stress
- mobilisation after illness
- major limb amputation
- incorrect type of insulin/oral hypoglycaemic therapy
- change of insulin injection site

reduced carb intake
- missed/delayed meals
- change of timing of meals
- lack of access to between meal snacks
- reduced appetite
- vomiting

59
Q

how is hypoglycaemia treated in adults who are conscious and able to swallow but confused, disoriented

A
  • 1.5-2 tubes of glucogel or dextrogel squeexed between teeth and gums
  • 1mg IM glucagon
60
Q

describe the pathophysiology of T2DM

A
  • repeated exposure to glucose and insulin make the cells in the body resistant to the effects of insulin
  • over time pancreas becomes fatigued and damaged so insulin output is reduced
  • high carb diet + insulin resistance + reduced pancreatic functio –> chronic hyperglycaemia –> micro/macrovascular complications + infections
61
Q

what are non-modifiable risk factors of T2DM

A
  • older age
  • ethnicity
  • FHX
62
Q

what are modifiable risk factors of T2DM

A
  • obesity
  • sedentary lifestyle
  • high carb diet
63
Q

what are possible presenting features of diabetes

A
  • Tiredness
  • Polyuria and polydipsia (frequent urination and excessive thirst)
  • Unintentional weight loss
  • Opportunistic infections (e.g., oral thrush)
  • Slow wound healing
  • Glucose in urine (on a dipstick)
64
Q

what clincial sign is associated with insulin resistance

A

Acanthosis nigricans - characterised by the thickening and darkening of the skin (giving a “velvety” appearance), often at the neck, axilla and groin

65
Q

what is pre-diabetes

A
  • indication that the patient is heading towards diabetes
  • do not fit the full diagnostic criteria but should be educated about the risk of diabetes and lifestyle changes
    HbA1c: 42-47 mmol/mol
66
Q

what HbA1c level indicates T2DM

A

48 mmol/mol or above

sample is typically repeated after 1 month to confirm the diagnosis

67
Q

what are the NICE guideline recommendations on managing T2DM

A
  • A structured education program
  • Low-glycaemic-index, high-fibre diet
  • Exercise
  • Weight loss (if overweight)
  • Antidiabetic drugs
  • Monitoring and managing complications
68
Q

what are the treatment targets for diabetics

A
  • 48 mmol/mol for new type 2 diabetics
  • 53 mmol/mol for patients requiring more than one antidiabetic medication
69
Q

how often is HbA1c measured

A

every 3 to 6 months until under control and stable

70
Q

what is 1st line medical management of T2DM

A

metformin
- once settled, add SGLT-2 inhibitor e.g. dapagliflozin if pt has exisitng CVD or HF

71
Q

in what patients does NICE recommend adding an SGLT-2 inhibitor to treatment regime

A

QRISK > 10%

72
Q

what is 2nd line treatment for T2DM

A

add a sulfonylurea, pioglitazone, DPP-4 inhibitor or SGLT-2 inhibitor

73
Q

what is 3rd line treatment for T2DM

A
  • Triple therapy with metformin and two of the second-line drugs
  • Insulin therapy (initiated by the specialist diabetic nurses)
74
Q

what option is appropriate if triple therapy fails and pt BMI >35

A

switch one of the drugs to a GLP-1 mimetic (e.g., liraglutide)

75
Q

what can pt experiencing GI side effects from metformin trial as an alternative

A

modified release metformin

76
Q

what is HHS

A

rare but potentially fatal complication of type 2 diabetes
- characterised by hyperosmolality > 320 mosmol/kg (water loss leads to very concentrated blood), hyperglycaemia and the absence of ketones

absence of ketones distinguishes it from ketoacidosis

77
Q

what is the pathiphysiology of HHS

A

hyperglycaemia = ↑ serum osmolality → osmotic diuresis → severe volume depletion

78
Q

what are precipitating factors of HHS

A
  • intercurrent illness
  • dementia
  • sedative drugs
79
Q

how can DKA and HHS be differentiated

A
  • DKA complication of T1DM, HHS normally in elderly pt w T2DM
  • ketones present in DKA
  • DKA presents within hours but HHS can come on over many days
80
Q

what are potential signs and symptoms of HHS

A
  • clinical signs of dehydration: skin turgor, dry mucous membranes
  • polyuria, polydipsia
  • lethargy, N&V
  • altered consciousness, focal neuro deficits
81
Q

what is a haematological sign of HHS

A

hyperviscosity –> MI, stroke, peripheral arterial thrombosis

82
Q

what is the management of HHS

A
  • IV 0.9% NaCl at 0.5-1L/hr
  • monitor K+ levels and add to fluids accordingly
  • VTE prophylaxis due to hypervisocity
83
Q

should insulin be given as part of treating HHS

A

insulin should NOT be given unless blood glucose stops falling whilst giving IV fluids

84
Q

how is hypoglycaemia treated in adults who are unconscious and unable to swallow/ NBM

A
  • check ABC
  • stop IV insulin
  • IV glucose over 15 mins as 75ml 20% glcuose or 150ml 10% glcuose
  • 1mg IM glucagon
  • recheck glucose after 10mins, if <4.0 mmol/L, repeat
85
Q

what is stress hyperglycaemia

A

transient hyperglcyaemia which normalises after discharge

86
Q

what is the pathophysiology of hyperglycaemia in acute illness

A
  1. increased gluconeogenesis
  2. accelerated glycogenolysis
  3. impaired glucose utilisation by peripheral tissues
87
Q

give 4 consequences of hyperglycaemia in a hospital setting

A
  • inc in-hospital morbidity and mortality
  • inc length of stay
  • poorer post discharge outcomes
  • excess health care costs
88
Q

what are the diagnostic criteria of HHS

A
  • Plasma glucose >30.0mmol/L
  • pH >7.3
  • Serum bicarbonate >15.0mmol/L
  • Plasma ketones <3.0mmol/L
  • Serum osmolality >320mOmol/kg
89
Q

what are you looking for in general assessment of diabetic foot

A
  • visibly unwell
  • drowsy
  • abnormal breathing
  • abnormal pulse
  • fever

urgent hospital admission

90
Q

what are 3 signs of active foot disease

A

ulceration
gangrene
cellulitis

91
Q

what are you examining for in foot disease

A
  • foot temperature >2 degrees difference between same point on both feet
  • presence of pulses (monophasic, biphasic, etc)
92
Q

what does it indicate if the foot is cold, pale or dusky

A

ischaemia

urgent hospital admission

93
Q

what does it indicate if foot is warm, red, swollen

A

acute infection and/or charcot foot

urgent hospital admission

94
Q

what are appropriate investigations into diabetic foot following hospital admission

A
  • weight bearing x-ray
  • soft tissue from wound and swab
  • bloods: FBC, CRP, U&Es, HbA1c, blood culutures
95
Q

what conditions can cause a falsely low HbA1c level

A
  • sickle cell anaemia
  • hereditary spherocytosis
  • G6PDH deficiency